LumbaCurve has been successful in landing its first order from the multinational TV shopping channel QVC. The revolutionary back pain relief device successfully completed independent clinical trials earlier this year, and was found to be significantly more effective than NHS standard guidelines (NICE) for the treatment of simple mechanical low back pain.
Indeed Patient Reported Outcome Measures (PROMS) indicated pain relief 6 times greater using LumbaCurve for just 7 days! An abstract of the results appeared in The Bone and Joint Journal and the full research paper is pending with the European Spine Journal.
The patented device focuses on the lumbar region (L4 / L5 / S1) where most back pain occurs, initially providing a passive gravity assisted traction (PGAT), with LumbaCurve acting as a fulcrum to stretch or extend the lower back to separate or decompress the vertebral joints, thus relieving pressure on the inter-vertebral discs. A gentle pelvic rocking motion attempts to mobilise the facet joints, whilst the LumbaCurve surface shaping is designed to provide an element of shiatsu or acupressure stimulation.
LumbaCurve CEO David Pegg commented, “We are delighted to receive our first order from QVC as this is indicative of the growing market interest in the product. Additionally since LumbaCurve can be used by both healthcare professionals, and individuals for self help, the TV exposure will create a far greater brand awareness of LumbaCurve across both channels, both domestically and internationally.”